M&A Deal Summary |
|
|---|---|
| Date | 2022-04-18 |
| Target | Inform Diagnostics |
| Sector | Life Science |
| Buyer(s) | Fulgent |
| Sellers(s) | Avista Healthcare Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 170M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2011 |
| Sector | Life Science |
| Employees | 1,313 |
| Revenue | 283M USD (2024) |
Fulgent is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. Fulgent was founded in 2011 and is based in El Monte, California.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Life Science M&A | 2 of 3 |
| Type: Add-on Acquisition M&A Deals | 2 of 3 |
| State: Texas M&A | 1 of 1 |
| Country: United States M&A | 2 of 3 |
| Year: 2022 M&A | 1 of 2 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-08-09 |
CSI Laboratories
Alpharetta, Georgia, United States CSI Laboratories provides a client- and patient-focused model of cancer diagnostic testing for pathologists, community hospitals and their patients. CSI Laboratories offers flow cytometry, cytogenetic analysis, fluorescence in-situ hybridization (FISH), immunohistochemistry, molecular genetics, next-generation sequencing, and consultations to hematopathology and surgical pathology clients. CSI Laboratories was founded in 1997 and is based in Alpharetta, Georgia. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-11-07 |
Fulgent Pharma
Temple City, California, United States Fulgent Pharma is an independent clinical-stage, therapeutics development company focused on the development of innovative cancer treatments. Fulgent Pharma is based in Temple City, California. |
Buy | $100M |
| Category | Private Equity Firm |
|---|---|
| Founded | 2005 |
| PE ASSETS | 8.0B USD |
| Size | Mega |
| Type | Sector Focused |
Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 30 of 31 |
| Sector: Life Science M&A | 7 of 7 |
| Type: Add-on Acquisition M&A Deals | 15 of 15 |
| State: Texas M&A | 6 of 6 |
| Country: United States M&A | 24 of 25 |
| Year: 2022 M&A | 1 of 1 |
| Size (of disclosed) | 11 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-15 |
Probo Medical
Tampa, Florida, United States Probo Medical is a provider of equipment sales, part sales, equipment rentals, depot repair service, equipment installation and de-installation, and field-based repair services. Probo Medical was founded in 2014 and is based in Tampa, Florida. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-08-23 |
WellSpring Consumer Healthcare
Sarasota, Florida, United States WellSpring Consumer Healthcare is a marketer of over-the-counter and cosmetic brands in the skincare, feminine hygiene, and gastrointestinal care categories. WellSpring’s portfolio includes Bactine, Bonine, FDS, Emetrol, Micatin, Gelusil, Glaxal Base, Barriere, and K-Lyte. WellSpring Consumer Healthcare was founded in 1999 and is based in Sarasota, Florida. |
Buy | - |
